Eiken Expands Diagnostics Products In Europe And Emerging Markets
This article was originally published in PharmAsia News
Executive Summary
Tokyo-based diagnostics maker Eiken Chemical aims to increase overseas sales by 10.9 percent to ¥1.8 billion by 2011, through strengthening marketing of occult fecal blood testing agents and products using loop-mediated isothermal amplification (LAMP) in Europe and emerging markets